Gustavo A. Rosario Benitez

Array ( [id] => 4834139 [patent_doc_number] => 20080132686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I RECEPTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/869250 [patent_app_country] => US [patent_app_date] => 2007-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17176 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132686.pdf [firstpage_image] =>[orig_patent_app_number] => 11869250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6448094 [patent_doc_number] => 20100105136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'CHIMERIC T-CELL RECEPTORS AND T-CELLS TARGETING EGFRVIII ON TUMORS' [patent_app_type] => utility [patent_app_number] => 12/444090 [patent_app_country] => US [patent_app_date] => 2007-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 18748 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105136.pdf [firstpage_image] =>[orig_patent_app_number] => 12444090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4921455 [patent_doc_number] => 20080069770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'NUCLEOTIDE SEQUENCE CODING FOR VARIABLE REGIONS OF BETA CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDE SEGMENTS AND THE DIAGNOSTIC AND THERAPEUTIC USES' [patent_app_type] => utility [patent_app_number] => 11/867862 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10007 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20080069770.pdf [firstpage_image] =>[orig_patent_app_number] => 11867862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774763 [patent_doc_number] => 08119772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'MART-1 T cell receptors' [patent_app_type] => utility [patent_app_number] => 11/864841 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25987 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119772.pdf [firstpage_image] =>[orig_patent_app_number] => 11864841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 201964 [patent_doc_number] => 07632500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Monoclonal antibodies against HMGB1' [patent_app_type] => utility [patent_app_number] => 11/903129 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 54 [patent_no_of_words] => 24745 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632500.pdf [firstpage_image] =>[orig_patent_app_number] => 11903129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270881 [patent_doc_number] => 20090074657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/902194 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17345 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074657.pdf [firstpage_image] =>[orig_patent_app_number] => 11902194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11262243 [patent_doc_number] => 09486524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 12/310544 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 14838 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12310544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4802587 [patent_doc_number] => 20080014174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Method for treating tumors, infectious diseases, and autoimmune diseases with an activated HLA matching donor-originating lymphocyte' [patent_app_type] => utility [patent_app_number] => 11/834342 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9172 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014174.pdf [firstpage_image] =>[orig_patent_app_number] => 11834342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9112890 [patent_doc_number] => 08569059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Method of identifying CD4+ CD25+ T-cells activated to an antigen which express CD8' [patent_app_type] => utility [patent_app_number] => 12/376019 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12682 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12376019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5230310 [patent_doc_number] => 20070292417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Chimeric allgraft tolerance induction, monitoring and maintenance' [patent_app_type] => utility [patent_app_number] => 11/782520 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16842 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292417.pdf [firstpage_image] =>[orig_patent_app_number] => 11782520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373690 [patent_doc_number] => 20090311251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'SCFV ANTIBODIES WHICH PASS EPITHELIAL AND/OR ENDOTHELIAL LAYERS' [patent_app_type] => utility [patent_app_number] => 12/307875 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19192 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311251.pdf [firstpage_image] =>[orig_patent_app_number] => 12307875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4773101 [patent_doc_number] => 20080058762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Induction And Maintenance Of Tolerance To Composite Tissue Allografts' [patent_app_type] => utility [patent_app_number] => 11/773803 [patent_app_country] => US [patent_app_date] => 2007-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12283 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058762.pdf [firstpage_image] =>[orig_patent_app_number] => 11773803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657086 [patent_doc_number] => 20080025947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Methods for enhancing the efficacy of IL-2 mediated immune responses' [patent_app_type] => utility [patent_app_number] => 11/825220 [patent_app_country] => US [patent_app_date] => 2007-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22302 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025947.pdf [firstpage_image] =>[orig_patent_app_number] => 11825220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446051 [patent_doc_number] => 20090047277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'RECOMBINANT IL-9 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/769326 [patent_app_country] => US [patent_app_date] => 2007-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 103240 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047277.pdf [firstpage_image] =>[orig_patent_app_number] => 11769326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314384 [patent_doc_number] => 20100111982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'RHEUMATOID ARTHRITIS T CELL VACCINE' [patent_app_type] => utility [patent_app_number] => 12/306894 [patent_app_country] => US [patent_app_date] => 2007-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7617 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111982.pdf [firstpage_image] =>[orig_patent_app_number] => 12306894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4493662 [patent_doc_number] => 07947273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Human antibody molecules for IL-13' [patent_app_type] => utility [patent_app_number] => 11/821880 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 39 [patent_no_of_words] => 35955 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947273.pdf [firstpage_image] =>[orig_patent_app_number] => 11821880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580533 [patent_doc_number] => 20090175879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'NOVEL TARGET IN THE TREATMENT OF CYTOKINE RELEASE SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/305250 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5204 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175879.pdf [firstpage_image] =>[orig_patent_app_number] => 12305250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282905 [patent_doc_number] => 08217009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Allorestricted peptide-specific T cells' [patent_app_type] => utility [patent_app_number] => 12/304918 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5669 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12304918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764634 [patent_doc_number] => 20080175845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Methods for treating target joints in inflammatory arthritis using AAV vectors encoding a TNF antagonist' [patent_app_type] => utility [patent_app_number] => 11/818790 [patent_app_country] => US [patent_app_date] => 2007-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14804 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175845.pdf [firstpage_image] =>[orig_patent_app_number] => 11818790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5457849 [patent_doc_number] => 20090258001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Administration of anti-CD3 antibodies in the treatment of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 11/810235 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 15779 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258001.pdf [firstpage_image] =>[orig_patent_app_number] => 11810235 [rel_patent_id] =>[rel_patent_doc_number] =>)